Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 12/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.31 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4971260 | 0.83 | BRD4 (0.52) | BRD4PARP1CREBBPLMNAGAA | |
| SCHEMBL10358737 | 0.82 | NR3C1 (0.38) | BRD4PARP1CREBBPLMNAMEN1 | |
| SCHEMBL10358533 | 0.82 | BRD4 (0.41) | BRD4PARP1CREBBPLMNAGAA | |
| SCHEMBL4898103 | 0.82 | BRD4 (0.41) | BRD4PARP1CREBBPLMNAGAA | |
| SCHEMBL10359070 | 0.82 | BRD4 (0.38) | BRD4PARP1CREBBPLMNAGAA | |
| SCHEMBL4969155 | 0.82 | MEN1 (0.40) | BRD4PARP1CREBBPLMNAMEN1 | |
| SCHEMBL4971589 | 0.81 | LMNA (0.38) | BRD4PARP1CREBBPLMNAGAA | |
| SCHEMBL2070598 | 0.80 | PARP1 (0.56) | BRD4PARP1CREBBPBRPF1 | |
| SCHEMBL20983200 | 0.80 | PARP1 (0.56) | BRD4PARP1CREBBPBRPF1 | |
| SCHEMBL4968933 | 0.79 | BRD4 (0.37) | BRD4PARP1CREBBPLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2598511-B1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2018-07-04 | — | — | EP | disclosed |
| US-8835628-B2 | Stable and highly tunable metathesis catalysts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2014-09-16 | — | — | US | disclosed |
| US-8835628-B2 | Stable and highly tunable metathesis catalysts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2014-09-16 | — | — | US | disclosed |
| US-8835628-B2 | Stable and highly tunable metathesis catalysts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2014-09-16 | — | — | US | disclosed |
| US-20130197218-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUE CNRS (FR) | 2013-08-01 | — | — | US | disclosed |
| US-20130197218-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUE CNRS (FR) | 2013-08-01 | — | — | US | disclosed |
| US-20130197218-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUE CNRS (FR) | 2013-08-01 | — | — | US | disclosed |
| EP-2598511-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | Ecole Nationale Superieure de Chimie de Rennes (FR) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012013208-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2012-02-02 | — | — | WO | disclosed |
| WO-2012013208-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2012-02-02 | — | — | WO | disclosed |
| EP-1985297-A1 | CARBOXYLIC ACID COMPOUND AND USE THEREOF | Japan Tobacco, Inc. (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | JAPAN TOBACCO INC. (JP) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130197218-A1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | CYP4F11, CYP2F1, MPI | BRD4 3258/4885PARP1 1677/4885CREBBP 3679/4885 |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | GLS, SLC10A1, SOAT1 | BRD4 3303/4885PARP1 4774/4885CREBBP 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.